MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors. MedPacto, Inc. is based in Seoul, South Korea.
MedPacto Dividend Announcement
• MedPacto announced a annually dividend of ₩0.28 per ordinary share which will be made payable on . Ex dividend date: 2022-03-15
• MedPacto's trailing twelve-month (TTM) dividend yield is -%
MedPacto Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2022-03-15 | ₩0.28 | annually |
MedPacto Dividend per year
MedPacto Dividend Yield
MedPacto current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing MedPacto stock? Use our calculator to estimate your expected dividend yield:
MedPacto Financial Ratios
P/E ratio-6.09
PEG ratio1.03
P/B ratio2.52
ROE-37.77%
Payout ratio0.00%
Current ratio7.36
Quick ratio7.36
Cash Ratio3.51
MedPacto Dividend FAQ
Does MedPacto stock pay dividends?
MedPacto does not currently pay dividends to its shareholders.
Has MedPacto ever paid a dividend?
No, MedPacto has no a history of paying dividends to its shareholders. MedPacto is not known for its dividend payments.
Why doesn't MedPacto pay dividends?
There are several potential reasons why MedPacto would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will MedPacto ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While MedPacto has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is MedPacto a dividend aristocrat?
MedPacto is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is MedPacto a dividend king?
MedPacto is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is MedPacto a dividend stock?
No, MedPacto is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy MedPacto stocks?
To buy MedPacto you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy MedPacto stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy MedPacto stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.